Correlation of chromosomal imbalances by comparative genomic hybridization and expression of EGFR, PTEN, p53, and MIB-1 in diffuse gliomas

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1037-1043

  Yakut, Tahsin ^a   Gutenberg, Angelika ^b   Bekar, Ahmet ^a   Egeli, UNal ^a   Gunawan, Bastian ^b   Ercan, Ilker ^a   Tolunay, Sahsene ^a   Doygun, Muammer ^a   Schulten, Hans Jurgen ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Astrocytomas; Comparative genomic hybridization; Immunohistochemistry; Oligodendrogliomas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HER1 PROTEIN, HUMAN; MIB1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PTEN PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHILD; CHROMOSOME ABERRATION; FEMALE; GENETICS; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PRESCHOOL CHILD;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 34548544861     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1037     Document Type: Article

References (33)

1. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002. (Pubitemid 34212595)
2. Gupta M, Djalilvand A and Brat DJ: Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma. Am J Clin Pathol 124: 755-768, 2005. (Pubitemid 41532511)
3. Kelley TW, Tubbs RR and Prayson RA: Molecular diagnostic techniques for the clinical evaluation of gliomas. Diagn Mol Pathol 14: 1-8, 2005. (Pubitemid 40283855)
4. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA and Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479, 1998. (Pubitemid 28482012)
5. Koschny R, Koschny T, Froster UG, Krupp W and Zuber MA: Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet Cytogenet 135: 147-159, 2002. (Pubitemid 34786766)
6. Besson A and Yong VW: Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J Neurooncol 51: 245-264, 2001. (Pubitemid 32479298)
7. Romeike BF, Jung V, Feiden W, Moringlane JR, Zang KD and Urbschat SM: Distribution of epidermal growth factor receptor protein correlates with gain in chromosome 7 revealed by comparative genomic hybridization after microdissection in glioblastoma multiforme. Pathol Res Pract 197: 427-431, 2001. (Pubitemid 32544906)
8. Baeza N, Weller M, Yonekawa Y, Kleihues P and Ohgaki H: PTEN methylation and expression in glioblastomas. Acta Neuropathol (Berl) 106: 479-485, 2003. (Pubitemid 37265852)
9. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK and Steck PA: Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59: 1820-1824, 1999. (Pubitemid 29186149)
10. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P and Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6: 217-223, 1996.
11. Gunawan B, Schulten HJ, von Heydebreck A, Schmidt B, Enders C, Hoer J, Langer C, Schuler P, Schindler CG, Kuhlgatz J and Fuzesi L: Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J Pathol 202: 421-429, 2004. (Pubitemid 38456160)
12. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145: 1175-1190, 1994. (Pubitemid 24345665)
13. Burger PC, Minn AY, Smith JS, Borell TJ, Jedlicka AE, Huntley BK, Goldthwaite PT, Jenkins RB and Feuerstein BG: Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Mod Pathol 14: 842-853, 2001. (Pubitemid 32889241)
14. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG and Jenkins RB: Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosomes Cancer 42: 68-77, 2005. (Pubitemid 39582821)
15. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG and Louis DN: Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7: 839-845, 2001. (Pubitemid 32708719)
16. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A and Kirino T: Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 8: 196-201, 2002. (Pubitemid 34101478)
17. Ueki K: Oligodendroglioma: impact of molecular biology on its definition, diagnosis and management. Neuropathology 25: 247-253, 2005.
18. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, Bentz M, Gress T and Lichter P: Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56: 3803-3807, 1996. (Pubitemid 26272032)
19. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW and Jenkins RB: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144-4152, 1999. (Pubitemid 29363922)
20. Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS and Feuerstein BG: Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet 142: 1-7, 2003. (Pubitemid 36349255)
21. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE and Bigner DD: Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155: 375-386, 1999. (Pubitemid 29370388)
22. Kros JM, van Run PR, Alers JC, Beverloo HB, van den Bent MJ, Avezaat CJ and van Dekken H: Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH). J Pathol 188: 282-288, 1999. (Pubitemid 29317772)
23. Mendrzyk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Stange DE, Neben K, Fiegler H, Carter NP, Reifenberger G, Korshunov A and Lichter P: Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol 23: 8853-8862, 2005. (Pubitemid 46211532)
24. Jeuken JW, von Deimling A and Wesseling P: Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 70: 161-181, 2004. (Pubitemid 39545730)
25. Wiltshire RN, Herndon JE II, Lloyd A, Friedman HS, Bigner DD, Bigner SH and McLendon RE: Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications. J Mol Diagn 6: 166-179, 2004. (Pubitemid 39136643)
26. Rosso SM, van Dekken H, Krishnadath KK, Alers JC and Kros JM: Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 56: 1125-1131, 1997. (Pubitemid 27430474)
27. Balesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, de Sanctis S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES and Fisher RA: Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer 81: 1371-1377, 1999.
28. Chernova OB, Somerville RP and Cowell JK: A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17: 2873-2881, 1998. (Pubitemid 29010057)
29. Somerville RP, Shoshan Y, Eng C, Barnett G, Miller D and Cowell JK: Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression. Oncogene 17: 1755-1757, 1998. (Pubitemid 28482654)
30. Brunner C, Jung V, Henn W, Zang KD and Urbschat S: Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas. Cancer Genet Cytogenet 121: 124-127, 2000.
31. Reichardt W, Jung V, Brunner C, Klein A, Wemmert S, Romeike BF, Zang KD and Urbschat S: The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol Rep 10: 1275-1279, 2003.
32. Klein A, Reichardt W, Jung V, Zang KD, Meese E and Urbschat S: Overexpression and amplification of STK15 in human gliomas. Int J Oncol 25: 1789-1794, 2004.
33. Wemmert S, Ketter R, Rahnenfuhrer J, Beerenwinkel N, Strowitzki M, Feiden W, Hartmann C, Lengauer T, Stockhammer F, Zang KD, Meese E, Steudel WI, von Deimling A and Urbschat S: Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment. Neoplasia 7: 883-893, 2005.